Thus, the similarity in antibiotic biosynthesis was confirmed between these FT-group antibiotic-producing organisms. It was also found that the major fermentation product of M. olivasterospora is not FT-A (astromicin) but dactimicin.
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By taking advantage of low substrate-specificity of enzymes involved in antibiotic biosynthesis, directed conversion or incorporation of specific compoundsto new antibiotics has been successfully attempted in various actinomycete strains that produce antibiotics1~3). One such attempt was the biosynthetic conversion of foreign antibiotics (kanamycins ; KM's) to newantibiotics (combimicins) with a gentamicin (GM)-producing Micromonospora strain4). This conversion by the GM-biosynthetic enzymes was attempted based on the structural similarity between KMand a GM-intermediate so that KMmight be transformed by GM-biosynthetic enzymes. Resistance to KMby the GMproducing Micromonosporais probably a key point since it seems unlikely that the organism is capable of metabolizing KMif it is sensitive to KM.GM-producing strains of Micromonospora have been known to be resistant to KM5>6). Istamycins (IS's) are produced by Streptomyces tenjimariensis7^and share a pseudodisaccharide moiety with fortimicin (FT) produced by Micromonospora olivasterosporaQ~11) (Fig. 1 ). This structural similarities suggest a similarity in the antibiotic biosynthetic pathways and a possible resistance to each antibiotic by the producers. Weattempted the conversion of intermediates of both IS and FT by M. olivasterospora and S. tenjimariensis. It was our special interest whether S. tenjimariensis could form a new antibiotic (1-epidactimicin; EDC)from FT components because only this organism has been known to produce epimers in terms of NH2group at C-l position as shown in Fig. 1 .
As expected, bioconversion experiments verified the biosynthetic similarity between these two organisms and resulted in the formation of EDCfrom FT-B by S. tenjimariensis. It was also found that the major fermentation product of M. olivasterospora was not FT-A(astromicin) but dactimicin (DC) which was first reported with Dactylosporangium matsuzakiense12 > 13).
Materials and Methods

Strains Used
S. tenjimariensis U41 is a blocked mutant of IS-biosynthesis obtained by UV-irradiation of ISproducing strain SS-15O7. This strain is able to produce a small amount of IS-Y0 and -Xo but no detectable amount of other IS components such as IS-A3 and -B3 known as major fermentation products of the parental strain SS-1507. The strains U41 and FT-producing M. olivasterospora ATCC 21819 were used for conversion experiments.
IS's and FT's IS's ( Fig. 1) were obtained from Dr. S. Kondo, Institute of Microbial Chemistry. FT's and DCwere prepared from the cultured broth of M. olivasterospora as described elsewhere10.
Conversion of IS's and FT-B For conversion of IS components and FT-B, 5. tenjimariensis U41 was first cultivated with rotary shaking (180 rpm) at 27°C for 3 days in a liquid medium (100 ml; pH 7.0) consisting of the following; corn gluten meal 5.0%, wheat germ 2.0%, CaCO3 0.6% and MgSO4-7H2O 0.05%. This culture (1 ml) was transferred into an IS fermentation medium (100ml; pH 7.0) consisting of wheat germ 6.5%, soy bean oil 3.5%, sodium palmitate 0.05%, CaCO3 0.6% and MgSO4-7H2O 0.05%. After incubation at 27°C for 3 days with rotary shaking, an IS component (Yo, Xo, Ao, Bo, A, B, A3 or B3) or FT-B was added to the culture at 200 jug/rml. The incubation was continued for 7 more days. In case of M. olivasterospora, strain ATCC21819 was shake-cultured at 27°C for 3 days in a medium (100ml; pH 7.0) consisting of potato starch 2.0%, soy bean meal 2.0%, MgSO4-7H2O 0.1%, NaCl 0.3% and KH2PO4 0.1 %. This seed culture (1 ml) was transferred into an FT fermentation medium(100 ml; pH 7.0) consisting of dextrin 5.0%, soy bean meal neutralized (pH 6.0) with NaOHand passed through a column of Amberlite IRC-50 (Na+ -H+, 7 : 3). The adsorbed IS or FT compounds were eluted with 0.5 n H2SO4. After adjusted to pH 5.5 and concentrated, the resulting precipitate was removedfrom the eluate. Then the eluate was analyzed with a reverse-phase HPLC (Fig. 2 ) using a column of YMCgel ODS-5 ju (Yamamura Chemical Co., Japan) and an eluant, 4% aqueous acetonitril, containing 0.02 m sodium-1-pentasulfonate, 0.2 m sodium sulfate and 0.1 % acetic acid. Antibiotics eluted were monitored by UVabsorption at 344 nm following o-phtalaldehyde reaction of the eluate in boric acid (pH 10). Structures of the products were further analyzed by NMRusing Jeol JNM-GX400, if appropriate14).
Results
Conversion of IS's by S. tenjimariensis
The IS components produced by S. tenjimariensis SS-1507 were tested for conversion by the ISnonproducing mutant, U41 (Table 1) . Conversion products, IS-A3, -B3, -Ao and -Bo were detected from almost all substrates except for IS-A and -B. Formation of these four compounds from each other suggested a sort of biosynthetic network among these compounds. By contrast, IS-Y0 was not formed from any other IS compoundas substrate. Instead, it was converted to all the IS compounds but IS-A and -B. IS-X0 was formed only from IS-Y0 and converted clearly to IS-A3, -B3, -Ao and -Bo. On the other hand, a small amount of IS-A and -B were detected in almost all cultured broths. However, their formation seemed to be due to chemical decomposition by elevated pH of the cultured broth, but not to enzymatic reaction, because IS-A3 and -B3 are known to be easily Relative values of A and B types of istamycin to A type istamycins (1.0) accumulated by ll-day incubation were scored.
decomposed to IS-A and -B in alkaline pH8). In relation to conversion to epimeric compounds (A and B types) in terms of NH2group at C-l position, it was found that accumulation ratio of these epimers in fermentation broth of IS-producing strain SS-1507 varied depending on incubation temperature. As shown in Table 2 , accumulation of A type was higher than that of B type when incubated at 27°C and vice versa at 32°C.
Conversion of Intermediates of Foreign Antibiotics
The conversion experiments of IS components suggested that the biosynthetic pathway of IS was very similar to that of FT. Therefore, it seemed likely that intermediates of IS and FT could be converted to antibiotic substances by the FT (M. olivasterospora) and IS (S. tenjimariensis) producers.
Both producers were then examined for their resistance to FT-Aand IS-A which seemed to be another key factor for this conversion. These organisms showed a high resistance (at least 200^g/ml) to both IS-A and FT-A in fermentation media. Another point to note in this attempt was that formation of EDCfrom FT-B could be expected by the epimerase activity of S. tenjimariensis if FT-B was transformed through IS-biosynthetic pathway. Bioconversion results are summarized in Table 3 . S. tenjimariensis U41 formed DCand EDC from FT-B as expected. On the other hand, M. olivasterospora accumulated only IS-A3 and IS-B3 from IS-A0 and IS-B0, respectively, in a detectable amount as expected. No detectable IS-A or IS-B was accumulated.
The accumulation of formimidoylated-IS compounds (IS-A3 and -B3) was unexpected since the reported biosynthetic pathway of FT15>16) did not involve any formimidoylated compounds. Then, we analyzed the fermentation products of M. olivasterospora. It turned out that only FT-B and DCand not FT-A were detected (Table 3) . Similarly, IS-producing S. tenjimariensis SS-1507 did not accumulate IS-A and -B but IS-A3, -Ba, -Ao and -Bo as we reported previously8). (B) Istamycin (IS) biosynthesis by S. tenjimariensis. Dotted line: Conversion by M. olivasterospora.
Discussion
Conversion experiments of IS components by S. tenjimariensis suggested a possible pathway of the later steps of IS biosynthesis. As shown in Fig. 3 , the pathway from IS-Y0 to IS-A3 is very similar to that of FT-biosynthesis15'16).
However, the pathway does not involve IS-A and -B, although they were detected in a small amount. Formation of these two substances could be due to chemical degradation of IS-A3 and -B3 probably by a relatively long exposure to the elevated pH of the cultured broth. In the early stage of our study on the isolation of fermentation products of S. tenjimariensis, we reported that IS-A and -B were the major products70. However, we found later that IS-A and -B were not metabolic products but chemical degradation products of true major fermentation products (IS-A3 and -B3)8}. Both IS-A3 and -B3 are so unstable in alkaline solution that IS-A, -B, -A1? -Br, -A2 and -B2 can be detected if alkaline solution such as ammoniumhydroxide is used for elution of fermentation products adsorbed to cation exchange resin. Thus, minimizing exposure of IS fermentation products to alkaline pH resulted in the exclusive detection of IS-A3, -B3, -Ao and -Bo as shown in Table 3 . This was also true in M. olivasterospora ATCC21819. This strain did not form FT-A type compounds in both conversion of IS's (IS-A0 and -Bo) and FT fermentation, but formimidoylated compounds; i.e. IS-A3 and -B3 by conversion of IS compounds and dactimicin (=2"-Af-formimidoyl-FT-A) and FT-B by fermentation. Distinct difference in the antibiotic biosynthetic pathways of S. tenjimariensis from M. olivasterospora is the production of epimers. Because of the epimerase activity of S. tenjimariensis, the final steps of IS-biosynthesis will form a kind of metabolic grid as shown in Fig. 3 . Neither M. olivasterospora nor any other FT-group antibiotic producer has been known to produce epimers of their antibiotics. This fact was one of the basis for our speculation that a new antibiotic (EDC) would be formed from FT-B by S. tenjimariensis.
Based on our study17), the resistance mechanism of S. tenjimariensis to FT-group antibiotics seems to be dependent on ribosomal resistance and not to inactivating enzymes. This was another basis of our attempt. If the biochemical basis of the resistance was dependent upon an inactivating enzyme, conversion of foreign antibiotics might result in the formation of inactivated substances. The same situation can be seen in the GM-producing strain of Micromonosporawhich produces combimicins from KM's. The resistance mechanism of a GM-producing strain of Micromonospora^has been known to depend upon ribosomal resistance. It should be also noted that S. tenjimariensis failed to convert aminoglycoside antibiotics other than the FT-group to antibiotic compounds,although the organism was resistant to these antibiotics (unpublished data). Furthermore, the GM-producing Micromonospora strain, which was used for the production of combimicins from KM,failed to convert neamine which has a structural similarity to GM(unpublished data). This failure could be related with the sensitivity to neamine of the strain. In a deoxystreptamine-negative mutant of Micromonosporainyoensis which produces sisomicin, conversion of neamine to sisomicin has been reported18*. However, the conversion rate from neamine was muchlower than that from paromamine. This difference might also be due to the difference in the resistance to paromamine and neamine of the sisomicin producer. Thus, both structural similarity and resistance mechanismsas well as the substrate specificity of biosynthetic enzymes should be key factors for antibiotic-producing actinomycetes to convert foreign antibiotics to novel antibiotics.
Although successful, the conversion rate of FT-B to DCand EDCby S. tenjimariensis was as low as 1 %as in the case of mutasynthesis or combimicins. This low conversion rate may be improved by establishing the suitable conditions for the conversion or by strain improvement. A promising strain improvement will be the construction by gene technology of FT-producing M. olivasterospora which contains genes directing the synthesis of IS-biosynthetic enzymes.
